The Present Status of I-131 Therapy for Graves' Hyperthyroidism in Japan (Survey by Questionnaire)

Kakuigaku

Volumn 40, Issue 4, 2003, Pages 457-463

  Ikekubo, Katsuji ^a   Kusakabe, Kiyoko ^b   Kanaya, Shinichi ^b   Ishikawa, Naofumi ^c   Nakada, Kunihiro ^d   Mori, Yutaka ^e  

^a KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c ITO HOSPITAL   (Japan)

^d HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Graves' disease; Hyperthyroidism; I 131 therapy; Japan; Questionnaire

Indexed keywords

ANTITHYROID AGENT; IODINE 131;

CONTROLLED STUDY; DIET THERAPY; DRUG HALF LIFE; ECHOGRAPHY; GRAVES DISEASE; HEART DISEASE; HUMAN; JAPAN; LIVER DISEASE; LONG TERM CARE; MAJOR CLINICAL STUDY; PALPATION; QUESTIONNAIRE; RADIATION DOSE; RADIOISOTOPE THERAPY; REVIEW; SIDE EFFECT; THYROID SCINTISCANNING; THYROID WEIGHT;

ADOLESCENT; ADULT; GRAVES DISEASE; HUMANS; IODINE RADIOISOTOPES; JAPAN; QUESTIONNAIRES;

EID: 0942297828     PISSN: 00227854     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Mori T, Sugawa H, Kosugi S, Ueda M, Hai N, Matsuda A: Recent trends in the management of Graves' hyperthyroidism in Japan: Opinion survey results, especially on the combination therapy of antithyroid drug and thyroid hormone. Endocr J 1997; 44: 509-517.
2. Vanderlaan WP, Storrie VM: A survey of the factors controlling thyroid function, with especial reference to newer views on antithyroid substances. Pharmacol Rev 1955; 7: 301-334.
3. Jpn J Clin Pharmacol Ther 1986; 17: 271-272.
4. Herts S, Robert A: Application of radioactive iodine in the therapy of Graves' disease. J Clin Invest 1942; 21: 624.
5. Franklyn JA, Maisonneuve P, Sheppard M, Betteridge J, Boyle P: Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study. Lancet 1999; 353: 2111-2115.
6. Sanger EL, Thoma GE, Thompkins EA: Incidence of leukemia following treatment of hyperthyroidism. J Nucl Med 1976; 17: 826-835.
7. Nagayama Y, Izumi M, Nagataki S: The management of hyperthyroidism due to Graves' disease in Japan in 1988. Endocr J 1989; 36: 299-314.
8. Glinoer D, Hesch D, Lagasse R, Laurberg P: The management of hyperthyroidism due to Graves' disease in Europe in 1986: results of international survey. Acta Endocrinol 1987; 115 (Suppl 285): 1-23.
9. Tominaga T, Yokoyama N, Nagataki S, Cho BY, Koh CS, Chen JL, et al: International differences in approaches to 1311 therapy for Graves' disease: Case selection and restrictions recommended to patients in Japan, Korea, and China. Thyroid 1997; 7: 217-220.